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Summary 
Newly assembled heavy chain-[32m heterodimers of class I histocompatibility molecules associ- 
ate with the endoplasmic reticulum (ER) peptide transporter, TAP, and subsequently dissociate 
from TAP in parallel with their transport from the ElL to the Golgi apparatus. It appears that 
TAP-associated class I molecules are waiting to bind appropriate peptides before they dissociate 
from TAP and leave the ER since binding of high affinity peptides to class I molecules in vitro 
leads to dissociation of TAP-class I complexes. In further support of this notion, we report that 
limiting peptide supply through inhibition of proteasome activities prolongs the association of 
mouse class I molecules with TAP and concomitantly slows their transport to the Golgi appara- 
tus. By using a series of deletion mutants and hybrid class I molecules we demonstrate that the 
extracellular domains of class I molecules are sufficient for their peptide-regulated interaction 
with  TAP.  Furthermore,  based on the  inability of an or.  3 domain-specific mAb to  recognize 
TAP-class I complexes and the fact that a point mutant of the D d molecule at residue 222 is 
unable to bind to TAP, it is likely that a major site of interaction with TAP resides in the mem- 
brane-proximal region of the heavy chain %  domain.  Finally, we examined the relationship 
between the interaction of mouse heavy chain-[32m heterodimers with TAP and with the resi- 
dent ElL chaperone, calnexin. Most heterodimers that bound to TAP were found to associate 
simultaneously with calnexin. Upon delivery of peptide to class I molecules in permeabilized 
cells,  dissociation from TAP was observed but the interaction with calnexin was largely main- 
tained. Therefore, both TAP and calnexin may participate in the ER retention ofpeptide-defi- 
cient  class  I  molecules.  However,  since  release from calnexin  occurs  after dissociation  from 
TAP, it appears that calnexin ultimately determines if a class I molecule is to be exported from 
the ElL. 
C 
lass I molecules of the major histocompatibility com- 
plex  (MHC)  bind  peptides  derived  from  endoge- 
nously  synthesized  proteins  and  present  them  at  the  cell 
surface to CD8 + cytotoxic T lymphocytes. Functional class 
I  molecules  consist  of  three  components:  an  MHC- 
encoded  transmembrane heavy chain  (H chain),  a soluble 
protein  termed  [32-microglobulin  ([32m)  1,  and  a  peptide 
ligand that is typically 8-10 residues in length.  The major- 
1Abbreviations used in  this paper: [32m  ,  [32-microglobulin; DSP, dithio- 
bis(succinimidyl propionate); endo H, endoglycosidase  H; ER, endoplas- 
mic reticulum; GPI, glycosytphosphatidylinositoI;  H chain, class t heavy 
chain; LLnL, N-acetyl-Dleucinyl-L-leucinyl-L-norleucinal;  PMSF, phe- 
nylmethylsulfonylfluoride; TAP, transporter-associated  with antigen pro- 
cessing. 
ity of peptides found associated with  class I molecules are 
derived from nuclear  and  cytosolic proteins  and  they  are 
generated largely through the proteolytic action of the cy- 
tosolic  proteasome  complex.  Peptides  are  delivered  from 
the cytosol into the lumen of the ER and possibly the cis- 
Golgi by the transporter associated with antigen processing 
(TAP)  and  subsequently  those  peptides  of  appropriate 
length and sequence bind to class I molecules (1, 2). 
The TAP transporter functions as a heterodimer of two 
MHC-encoded polypeptides, TAP1  and TAP2. Each sub- 
unit  is  predicted  to  span  the  ER  membrane six  to  eight 
times with only small loops penetrating the ER lumen and 
with a large domain containing an ATP binding cassette re- 
siding in the cytosol (1, 3, 4). TAP1 and TAP2 proteins are 
located in the ER and ds-Golgi as determined by immuno- 
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lack known  sequences  that  would  confer this localization 
(5, 6). Experiments with either isolated microsomes or per- 
meabilized cells have shown that TAP preferentially trans- 
ports peptides of 8-15 residues in an ATP-dependent fash- 
ion. Furthermore, in rat and mouse there is some sequence 
selectivity for the carboxy terminus of peptides which may 
favor peptides with higher binding affinity for class I mole- 
cules (1, 3, 4, 7, 8). 
We and others have demonstrated that newly assembled 
mouse and human  H  chain-[32m heterodimers, but not H 
chains alone, associate with TAP and that subsequent disso- 
ciation from  the  transporter occurs  in parallel with  class I 
movement  from  the  EP,  to  the  Golgi (9,  10).  Moreover, 
delivery of known  peptide ligands to  class  I  molecules in 
permeabilized cells leads to the dissociation of TAP-class I 
complexes. On the basis of these data we proposed a model 
wherein  newly  assembled  class  I  heterodimers  associate 
with TAP, capture appropriate peptide ligands in a process 
facilitated by their proximity to  the  transporter,  and  then 
dissociate from  TAP  for subsequent  rapid transport to the 
cell surface (9). In addition to enhancing access to peptides, 
the  association with  TAP  may  help  to  retain  class  I  het- 
erodimers within the Elk until peptides are acquired. 
Assembling class I molecules also associate with calnexin, 
a  molecular chaperone  that  resides within  the  Elk  mem- 
brane (11).  In the mouse, newly synthesized H  chains bind 
rapidly and  quantitatively  to  calnexin  and  remain  bound 
during assembly with ~2nl  (12,  13). Dissociation from cal- 
nexin, like TAP, occurs in parallel with the transport of as- 
sembled class I  nmlecules from  the  Elk to  the Golgi (12). 
During this interaction, calnexin promotes folding of class I 
H  chains and their assembly with  ]32m (14).  Furthermore, 
calnexin retains class I assembly intermediates in the ER so 
that  for the  most  part  only fully assembled,  peptide-con- 
taining class I  molecules are transported to the cell surface 
(13,  15).  Calnexin also retains human  class I  H  chains and 
facilitates their folding (14,  16,  17).  However,  there  have 
been  several  reports  suggesting  that  in  humans  calnexin 
binds only to  free  H  chains  and  dissociates upon  H  chain 
assembly with ~2  m  (10,  18,  19).  In contrast, Carreno et al. 
recently reported that  calnexin does indeed associate with 
hulnan H  chain-]32m heterodimers (20).  Additional studies 
are required to determine if the apparent disparity between 
the mouse  and human  systems is correct or if it has arisen 
through  technical  problems  in  detecting  calnexin  com- 
plexes with human class I heterodimers. 
There are a number of unresolved issues surrounding the 
interaction of assembling class I  molecules with both TAP 
and calnexin. For example, what is the molecular nature of 
these associations? Calnexin has been  shown  to  recognize 
class I H  chains via a carbohydrate binding site that has af- 
finity for the GlqMan,~GlcNAc  2 oligosaccharide processing 
intemlediate  (14,  21,  22)  and  also through  interactions in 
the  vicinity of the  H  chain  transmembrane  segment  (23, 
24).  However,  the site(s) on  class I  molecules that interact 
with TAP have not been identified. This issue is of particu- 
lar interest since the association seems to be dependent on 
the  assembly state of class I.  Furthermore,  given that sub- 
stantial  populations  of  class  I  heterodimers  have  been 
shown  to  bind  to  calnexin  and  TAP  (9,  12),  do  ternary 
complexes of the proteins exist? Finally, the  nature  of the 
folding or assembly event leading to  calnexin dissociation 
has remained elusive. Does peptide binding to class I influ- 
ence this process in a manner analogous to its effects on the 
interaction  with  TAP?  These  issues  are  addressed  in  the 
present study. 
Materials and Methods 
Cells and Antibodies.  The munne T cell lymphoma EL4 (H-21'), 
the lymphoreticular tuxnor line MDAY-D2 (H-2d),  and the mu- 
rine thymoma R1.1  (H-2  k) were maintained in RPMI 1640 me- 
dium supplemented with 2 mM glutamine, 10% FCS, and antibi- 
otics. Transfected Fr  cells expressing either the D ~ molecule, 
D b lacking all but three amino acids of its cytoplasmic domain 
(Di'-cyt), the glycosyl phosphatidylinositol (GPl)-anchored Q7  b 
molecule, or the GPl-anchored Dh/Q7 b hybrid molecule (D%p/ 
cpQ7  b)  have  been  described elsewhere  (23).  Rl.l  transfectants 
were  grown  in  the above RPMI  1640  medium containing 0.5 
mg/ml Geneticin (GIBCO BRL, Gaithersburg, MD). Mouse Ltk- 
cells  expressing soluble D d (Da/Q10)  were  a  gift of Dr.  David 
Margulies (NIAID, Bethesda, MD;  25).  L cells expressing wild- 
type D 'l or D a molecules having single Glu to Lys point nmtations 
at residues 222, 223, or 232 were provided by Dr. Ter  W A. Pot- 
ter  (National Jewish  Center  for  hnmunology  and  Respiratory 
Diseases, Denver, CO) and have been described previously (26). 
Ltk- cells and L cell transfectants were maintained in I)ME sup- 
plemented with 2 mM glutamine, 10% FCS and antibiotics. 
Rabbit antisera recognizing TAP1,  TAP2, and calnexin have 
been  described elsewhere  (9,  15).  For the selective isolation of 
unassembled class I H  chains, a rabbit antiserum raised against de- 
natured  mouse  H  chains  (anti-HC)  was  provided  by  Dr.  H. 
Ploegh and R. Machold (MIT, Cambridge, MA; 27).  mAb Y3, 
which recognizes the %  domain of K  t', was used for the selective 
isolation of ]32m-associated K  b molecules (28,  29).  For the isola- 
tion ofK  b H  chain regardless of assembly state, a rabbit antiserum 
(designated anti-8)  directed against the cytoplasmic peptide en- 
coded by exon 8 of the K b gene was used (29, 30). Anti-8 antise- 
rum was provided by Dr. Brian Barber (University of Toronto). 
mAb B22.249.R1  that recognizes the o~ 1 domain of I)  I' H  chain 
was  used for selective isolation of [32m-associated  I)  b molecules 
(31, 32)  whereas the a.~ domain-specific mAb 28-14-8s was used 
for isolation of both free and ]32m-associated  D b or L  d molecules 
(31-33). The oq domain-specific mAb 20-8-4s was used for iso- 
lation of ~2m-associated K  b and  Q7 t' molecules (29,  31).  mAb 
30-5-7s recognizes the 0r 2 domain of ~2m-associated L  a molecules 
(33) and mAb 34-2-12 recognizes the ot  3 domain ofD 't molecules 
(33) focusing on the polymorphism at residue 227  (26). I)  a mole- 
cules associated with ]32m were isolated with the c~-domain spe- 
cific mAb 34-5-8s (34). 
Reagents.  The  peptide  designated  Flu  NP  Y367-374  (se- 
quence  YSNENMETM)  corresponds to residues 367  to 374  of 
the influenza A/PR./8/1934 nucleoprotein with an additional ty- 
rosine at the amino terminus. VSV G  52-59 is a peptide corre- 
sponding to residues 52-59 of the vesicular stomatitis virus G pro- 
tein  (sequence  P, GYVYQGL).  Both  peptides were  synthesized 
by the Alberta Peptide Institute (Edmonton, Alberta) and judged 
to be more than 95% pure by P,P-HPLC. The protease inhibitor, 
LLnL  (N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal;  Siena Chem. 
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and was added to cell culture medium to a final concentration of 
100 ~M. Digitonin was obtained from Sigma  (~50% pure)  and 
solution concentrations were expressed in terms of actual digito- 
nin  content.  For  chemical  cross-linking experiments,  dithio- 
bis(succinimidyl  propionate) (DSP; Pierce  Chemical Co., Rock- 
ford,  IL)  was  used.  To  enhance  class  I  expression  in  certain 
transfected  L  cell  lines,  400  U/ml recombinant mouse  IFN-',/ 
(PharMingen, San Diego, CA) was added to the culture medium 
for 24 h. 
Metabolic Radiolabeling and Immunoprecipitation.  Metabolic  ra- 
diolabeling of EL4 cells and 1KI.1 transfectants  and immunopre- 
cipitation of class I molecules from digitonin cell lysates were per- 
formed  as  previously described  (9). Immune complexes  were 
eluted from the protein A-agarose beads with SDS-PAGE sample 
buffer either directly  or after endo H treatment as described  pre- 
viously (15) and then analyzed by SDS-PAGE and fluorography 
(12.5% gel). For experiments that included the protease  inhibitor 
LLnL,  cells were  preincubated in Met-free 1KPMI 1640  for 40 
nfin in the absence or presence  of 100 ~M LLnL and the inhibi- 
tor was also present throughout the subsequent pulse labeling and 
chase incubations. Chemical cross-linking experiments were per- 
fomaed with DSP as previously described  (12) except that digito- 
nin was used instead of NP-40 in the lysis buffer. 
For metabolic radiolabeling of L  cell transfectants,  a 60-ram 
dish of confluent cells was incubated in 3 ml of Met-free RPMI 
1640 for 30 rain and then radiolabeled  in 0.1  mCi/ml [35S]Met. 
Radiolabeled cells were lysed in 1 ml digitonin lysis buffer for 30 
rain at 4~  and the lysates were subjected to immunoprecipita- 
tion (9). 
Sequential Immunoprecipitation.  In some instances, a sequential 
immunoprecipitation  technique was employed for the analysis of 
TAP-associated class I molecules (9). Briefly,  TAP-class I com- 
plexes recovered in an initial round ofimmunoprecipitation  with 
anti-TAP2 antiserum and protein A-agarose beads were dissoci- 
ated by heating at 37~  for  lh in PBS, pH 7.4,  containing 0.2% 
SDS.  After  centrifugation to remove the beads,  the supernatant 
fraction was  adjusted  to  contain 2%  NP-40 and 5%  skim milk 
powder and then was subjected to a second round of immuno- 
precipitation with mAb 28-14-8s (for D  h and its derivatives)  or 
anti-8 antiserum (for Kb). Inmmne complexes  were washed only 
once with 0.5% NP-40, 10 n~l Tris, pH 7.4, 150 mM NaC1, 1 mM 
EDTA before elution and analysis by SDS-PAGE. For analysis of 
calnexin-associated  class I molecules,  anti-calnexin  antiserum was 
used  in an initial immunoprecipitation to  recover all calnexin- 
bound proteins. After dissociation of complexes  in SDS as above, 
K  b and D t' molecules were recovered sinmltaneously in a second 
round of immunoprecipitation  using a combination of anti-8 an- 
tiserum, mAb 28-14-8s, and anti-denatured H chain antiserum. 
Cell Permeabilization and Peptide Incubations.  P,  adiolabeled  cells 
were permeabilized with 0.003% digitonin and incubated in the 
absence or presence  of class I-binding peptides  to assess dissocia- 
tion of TAP-class I or calnexin-class I complexes as described be- 
fore  (9). After  incubation, cells were collected by centrifugation 
and lysed in 0.5 ml ofdigitonin lysis buffer. TAP-associated class I 
molecules were recovered either by direct immunoprecipitation 
with anti-TAP2 antisermn or by sequential immunoprecipitation. 
Calnexin-associated class I molecules were recovered by sequen- 
tial immunoprecipitation. 
Western Blot Analysis.  Proteins in anti-class I immunoprecipi- 
tates were separated by SDS-PAGE and electrophoretically trans- 
ferred to polyvinylidene  difluoride membranes (Millipore, Bedford, 
MA).  Membranes were probed with anti-TAP or anti-calnexin 
antibodies, and the bound antibodies were visualized with 12sI- 
protein A (ICN Pharmaceuticals  Inc., Costa Mesa, CA) and auto- 
radiography. 
Results 
Inhibition of Proteasome Activity Results in Prolonged TAP- 
Class I Association and Impaired Intracellular Transport of Class 
I Molecules.  Before  undertaking an  analysis of the  site(s) 
on class I molecules that interact with TAP, we wished to 
examine further the  effects of peptides on this association. 
Previous work has demonstrated that various peptide alde- 
hydes inhibit the supply ofpeptide ligands for class I mole- 
cules,  largely through  inhibition of cytosolic  proteasome 
activities (35). To assess the effect on the TAP-class I com- 
plex of limiting peptide supply, we performed pulse-chase 
experiments with EL4  cells in the  absence or presence of 
one of the peptide aldehyde inhibitors, LLnL. 
As shown in Fig.  1 A, TAP-class I complexes could be 
recovered at the various chase times by imrnunoprecipita- 
tion with anti-TAP2 antiserum. Deglycosylation of immu- 
noprecipitates with endoglycosidase H  (endo H) permitted 
the resolution of TAP-associated K b and D b heavy chains 
along with  associated  [32  m.  In  the  absence  of LLnL,  the 
amounts of TAP-class  I  complexes  increased to  a  maxi- 
mum level after 10-rain chase for K b and 30-rain chase for 
D b and  then  dissociated  such  that  half of the  complexes 
were lost by 35 rain of chase for K b and 74 rain of chase for 
D b (Fig. 1 B). The different rates of dissociation closely par- 
alleled the different rates at which K b and D b molecules are 
transported  from  the  Elk  to  the  Golgi  apparatus  in EL4 
cells, as established previously (9).  In contrast, in the pres- 
ence of LLnL, dissociation of class  I  molecules from TAP 
was substantially delayed such that the half time of dissocia- 
tion was observed at ~62 rain of chase for K b and at ~260 
min for D 6.  Another effect  of LLnL treatment was a  dra- 
matic increase in TAP-K  b complexes to  a maximum level 
4.2-fold greater than that observed in the absence of LLnL. 
No  such  increase  was  observed  for  TAP-D  b  complexes. 
Presumably,  under  conditions of normal peptide  supply, 
TAP-K  b complexes do not have the opportunity to accu- 
mulate extensively. Consistent with  the  subcellular local- 
ization of TAP in the Elk and cis-Golgl  (5,  6),  prolonged 
association of class  I  molecules with  TAP resulted in ac- 
cordingly slower intracellular transport of class I molecules 
as measured by their conversion to forms resistant to endo 
H  digestion. LLnL treatment slowed the half times of Elk 
to Golgi transport from "-'34 to ~60 rain for K b and from 
~75 to >120 rain for D b (data not shown). 
Extracellular Domains of Class I Molecules Are SufiTcient  for 
Association with TAP.  To  identify  the  site(s)  on  class  I 
molecules  that  interact with  TAP,  we  examined various 
truncated and hybrid class I molecules for their ability to as- 
sociate  with  TAP.  Fig.  2  A  depicts  the  class  I  molecules 
used in this study. Full-length D b, D b lacking all but three 
amino acids of its cytoplasmic tail (D6-cyt), GPI-anchored 
D b composed of the  extracellular domains of D b fused to 
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tion.  (A) Murine EL4 cells were preincubated in the absence or presence 
of 100 ~M LLnL for 40 rain, pulse labeled with [3SS]Met for 5  rain, and 
then chased for periods of up to 6  h. Cells were lysed in 0.5'% digitonin 
lysis  buffer and then immunoprecipitated with  anti-TAP2 antiserum to 
recover TAP-class I complexes. Immunoprecipitates were deglycosylated 
with  endo  H  and then analyzed by SDS-PAGE.  The mobilities of the 
TAP 1 and TAP 2 subunits, the K b and D b H  chains, and ~2  m are shown. 
The numbers on the right indicate the mobilities of molecular mass stan- 
dards in kD. (B) Densitometric analysis of the relative amounts ofK  b and 
D b H  chains in A. 
the  COOH-terminal  portion  of Q7 b in the middle  of their 
connecting  peptides  (Dbcp/cpQ7b),  and  the  GPI-anchored 
class I  Q7 b molecule,  were  all expressed in the murine  thy- 
morea  cell  line,  R1.1.  The  soluble  hybrid  class I  molecule 
Dd/Q10  was  expressed  in  murine  L  cells  and  consisted  of 
the oq,  o~2, and ot  3 domains  ofD  a fused to  the  COOH-ter- 
minal  27  amino  acids of the soluble class I  molecule,  Q10 b. 
Association  of the  various  class  I  molecules  with  TAP  was 
Figure  2.  Extracellular domains of class  I  molecules are  sufficient for 
TAP association. (A)  Schematic representation of truncated class I mole- 
cules used to map sites of interaction with TAP. cq, a2, and cx  3 represent 
the  three  extracellular  domains  of class  I  H  chains  consisting of "o90 
amino acids each.  TM  and CYT represent the H  chain transmembrane 
segment (24  residues for  D b)  and cytoplasmic segment (31  residues for 
D6),  respectively.  In the  soluble Da/Q10  hybrid molecule,  the  hatched 
boxes correspond to the (x  I, cr z, and ~x  3 domains ofD  a and the zigzag line 
represents the COOH-terminal 27 amino acids of the Q10  b molecule. (B) 
Detection  of complexes between  TAP  and truncated class  I  molecules. 
RI.I  or L cell  transfectants were radiolaheled for 30 min with  (35S]Met, 
lysed, and then immunoprecipitated with either anti-TAP2 antiserum to 
isolate TAP-class I complexes or with mAbs [322.249.R1  (for D t' and 196- 
cyt), 20-8-4S (for Q76), and 34-5-8S (for full-length D d and Da/Q10)  to 
isolate transfected class I molecules. To distinguish transfected class I mol- 
ecules from the endogenous K k and D k proteins, anti-TAP immunopre- 
cipitates were subjected either to sequential immunoprecipitation (in the 
case of R l.l(Dbcp/cpQ7b))  or to deglycosylation by endo H  before SDS- 
PAGE. Mobilities of endogenous H-2  k products are indicated by asterisks 
and  mohilities of transfected  class  I  molecules are  indicated  by  arrow- 
heads, i.p.  indicates the specificity of the antibody used for immunopre- 
cipitation and T1, T2, and [32 denote TAP  1,  TAP 2, and [32m, respec- 
tively.  For Dbcp/cpQ76, the first lane was exposed to film for a half day 
and the remaining lanes were exposed for 5 days. Note that full-length I) a 
contains a Glu to Lys mutation at residue 232. This mutant was used instead 
of wild-type D a because its synthetic rate was closer to that of Da/Q10. 
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beled cell lysates with anti-TAP2 antiserum and identifying 
co-precipitating class I molecules by SDS-PAGE. 
As shown  in the  first panel of Fig. 2  B,  anti-TAP anti- 
body coprecipitated the  endogenous  K k and D k molecules 
from untransfected R.1.1  cells (asterisks). These class I mol- 
ecules were  exclusively sensitive  to  endo  H  digestion,  as 
expected based on the localization of TAP in the ElL and 
cis-Golga. The  K k and D k molecules were present in  anti- 
TAP  immunoprecipitates of all the R.1.1  transfectants but 
could  generally be  resolved  from  the  heterologously  ex- 
pressed class I molecule either before or after digestion with 
endo  H.  For example, the  transfected D b molecule which 
was  observed to  interact with  TAP  in  EL4  cells  (Fig.  1), 
was also found associated with TAP in the II.1.1  (D  b) trans- 
fectant  (Fig.  2  B).  It could be  detected as the  lower band 
(arrowhead) of a doublet after endo H  digestion of the anti- 
TAP  immunoprecipitate.  Examination  of the  R1.1  trans- 
fectant expressing D b that lacked all but three  amino acids 
of its  cytoplasmic tail  (Fig.  2  B,  P,1.1  (Db-cyt))  revealed 
that the truncated molecule retained the ability to associate 
with TAP.  It was  easily resolved from endogenous  class I 
molecules in the anti-TAP precipitate due to its reduced size. 
Further truncation of D b was accomplished by replacing 
its  transmembrane  and  cytoplasmic segments  with  a  GPI 
anchor  (Dbcp/cpQ7b).  Due  to  low  expression levels, un- 
ambiguous  identification  of this  hybrid  molecule  in  the 
anti-TAP  precipitate  required  a  sequential  immunoisola- 
tion procedure. The anti-TAP precipitate was disrupted in 
SDS and then subjected to a second round of immunopre- 
cipitation with either anti-D  b mAb 28-14-8S  or an isotype 
matched  anti-I-A  d  mAb  (Fig.  2  B,  1K1.1 (Dbcp/cpQ7b)). 
The  GPI-anchored D b molecule was selectively recovered 
in the anti-D  b immunoprecipitate demonstrating that it was 
indeed associated with  TAP.  Confirmation  of this finding 
was obtained by assessing the ability of the naturally GPI- 
anchored  Q7  b molecule to  associate with  TAP  (Fig.  2  B, 
IK1.1  (Q7b)).  The  Q7 b molecule was almost quantitatively 
recovered  in  the  anti-TAP  immunoprecipitate  indicating 
that the transmembrane and cytoplasmic segments of class I 
H  chains are not required for interaction with TAP. How- 
ever, complete abolishment of any membrane  anchor dra- 
matically reduced the  amount  of class I  molecule co-pre- 
cipitating with  TAP.  Only  ,'o5%  of the  soluble Da/Q10 
class I molecule was found in association with TAP (Fig. 2 
B, Ltk- (Da/Q10).  This was not due to an inherent inabil- 
ity ofD d molecules to bind to TAP since the full-length D a 
protein was readily recovered in anti-TAP immunopfecip- 
itates (Fig. 2  B, Ltk- (full-length Da). 
Extracellular Domains of Class I Molecules Are Suflldent  for Pep- 
tide-regulated Interaction with TAP.  To determine whether the 
extracellular domains of class I molecules contain all of the 
elements  necessary  for  peptide-regulated interaction  with 
TAP, we tested two aspects of the TAP-class I interaction: 
dissociation  of  the  TAP-class  I  complex  upon  peptide 
binding to class I  and prolonged association of class I  with 
TAP under peptide limiting conditions. 
We established previously that upon incubation of digi- 
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Figure 3.  (A) Peptide-induced  dissociation of D  b and GPI-anchored 
D  b from  TAP.  R1.1  transfectants were  radiolabeled for  30  rain  with 
[35S]Met, permeabilized with 0.003% digitonin, and then incubated in the 
absence or presence of the  indicated concentrations of the  Db-binding 
peptide, Flu NP Y367-374. TAP-associated D  b molecules were isolated 
by sequential immunoprecipitation consisting  of an initial immunoprecip- 
itation with anti-TAP2 antiserum, solubilization of the immunoprecipi- 
tate, and a second immunoprecipitation with the anti-D b mAb, 28-14-8S. 
All samples were  deglycosylated with endo  H  before analysis by SDS- 
PAGE. The protein  denoted by the asterisk was also recovered when a 
control mAb was used in the second immunoprecipitation and thus was 
judged to be non-specific. (B) Both full-length D  b and GPI-anchored D  b 
remain associated with  TAP upon  peptide depletion with  LLnL. 11.1.1 
transfectants were preincubated for 40 min in Met-free kPMI 1640 me- 
dium containing either 0 or 100 IxM LLnL, labeled with [35S]Met for 30 
rain, and then chased for up to 6 h in the continued absence or presence 
of LLnL. At the  indicated times, TAP-associated D  b and Dbcp/cpQ7 b 
were isolated by sequential immunoprecipitation with anti-TAP2 antise- 
rum  followed by mAb  28-14-8S.  Asterisks denote  proteins recovered 
non-specifically  in the immunoprecipitates. 
tonin-permeabilized cells  with  peptide  ligands  for  class  I 
molecules, peptide binding to  class I  was  accompanied by 
dissociation of TAP-class I  complexes  (9).  Similar experi- 
ments were conducted on full-length D b and GPI-anchored 
Dbcp/cpQ7 b molecules expressed in R1.1  cells. As shown 
in  Fig.  3  A,  more  than  half of TAP-D  u  and  TAP-Dbcp/ 
cpQ7  b complexes dissociated at  10  nM  peptide.  Virtually 
complete dissociation of both  complexes was  observed at 
10 IxM peptide. 
To  test if proteasome inhibition prolongs association of 
GPI-anchored  D b  with  TAP,  we  performed  pulse-chase 
experiments in  the  absence  or presence  of LLnL  on  P,1.1 
transfectants expressing either full-length D b or Dbcp/cpQ7  b 
(Fig. 3  B). In the absence ofLLnL, DUcp/cpQ7  b molecules 
dissociated from  TAP  more  slowly than  was  observed for 
fi.dl-length D b (tl/2 ,"~175 rain vs "~75 rain, Fig. 3  B, -LLnL). 
In  the  presence  of LLnL,  the  amounts  of TAP-associated 
D b and Dbcp/cpQ7  u were substantially increased, reaching 
a maximum by 1-2 h  of chase. Furthermore, little dissocia- 
tion  of either  complex  was  observed  throughout  the  re- Figure 4.  A site of interaction  with TAP resides within the (x  3 domain 
of class I H chains.  (A) Isolation of TAP-class  I complexes with various 
anti-class I Abs. EL4 (H-2  b) or MDAY-D2 (H-2  d) cells were lysed and 
subjected  to immunoprecipitation  with antibodies  having the following 
specificities: 20-8-4S  (cq domain of Kb), 28-14-8S  (a  3 domain ofD  b and 
Ld), B22.249.tL1 (~x  I domain  ofl)  t' and Ld), anti-8  (cytoplasmic tail ofK  b 
and  Ka), and  30-5-7S  (cx2 domain of La). Co-isolated  TAP proteins  in 
these  immunoprecipitates  were  detected  with  a  mixture  of anti-TAP1 
and  anti-TAP2 antisera by Western  blot analysis. Lanes  1 and  5 depict 
anti-TAP1  and TAP2 imnrunoprecipitates  from one-twentieth (EL4) or 
one-quarter  (MDAY-D2)  the  volume of cell lysate used  in  the  other 
lanes. (B)  Interaction  of nmtant  D  a molecules with TAP. Untransfected 
tk- L cells (lane 1) or L cells expressing either wild-type D d (lanes 2 and 3) 
or nmtant  1)  r  molecules possessing a Glu to Lys mutation  at residues 222 
(lane 4), 223 (lane 5), or 232 (lane 6) were lysed and then imnmnoprecip- 
itated  with either a mixture of TAP1  and  TAP2 antiserum  (lane 2)  or 
with mAb 34-2-12S  to isolate I)  d molecules. TAP proteins  co-immuno- 
precipitating  with 1)  d were detected  by Western  blotting  with a nfixture 
of TAP1  and TAP2 antisera. Although  TAP synthesis was comparable in 
all transfectants (not shown),  wild-type 1)  d and mutant  E222K  exhibited 
low synthetic  levels  (see C).  To  compensate,  these  transfectants  were 
treated with 400 U/ml IFN-y for 24 h before lysis and three times more 
cells were used than in lanes 1, 5, and  6. The TAP1  and TAP2 signals in 
lane 2 were obtained from one-sixteenth  of the cell lysate used in lanes 1, 
5, and  6. (C) L ceI] transfectants (5  ￿  ~0  (' cells) expressing the indicated 
D  a molecules were radiolabeled with [3SS]Met for 30 rain, lysed, and then 
subjected  to mmmnoprecipitation  with mAb 34.2.12S.  [mmunoprecipi- 
maining  chase  period  up  to  6  h.  It  is  noteworthy  that  in 
LLnL-treated  EL4  cells,  significant  dissociation  of TAP-D b 
complexes  was  observed  over a  6-h  chase  period  (Fig.  1). 
The difference between EL4 and IL1.1  (D  b) may be due in 
part to the longer labeling time (30 min vs 5  rain)  used for 
P, 1.1  cells which was necessitated by the sequential  imnm- 
noprecipitation  technique  employed  for  these  ceils.  Alter- 
natively, EL4 cells may differ from R1. I  cells in the extent 
to which they produce  Db-binding peptides  by a  route not 
inhibitable by LLnL. Based on these data,  we conclude that 
the extracellular domains  of class I  molecules contain  all of 
the  elements  required  for  peptide-regulated  interaction 
with TAP. 
The Membrane Proximal Region of the Heavy Chain a 3 Do- 
main May Interact with  TAP.  Two lines of evidence are con- 
sistent with TAP binding to the %  domain of class  I H  chains. 
First,  mAb  28-14-8S,  which  is directed  against  the c~3 do- 
main ofD b and L d molecules, was not able to coprecipitate 
TAP  as revealed by Western  blotting of 28-14-8S  precipi- 
tates  from  EL4  (H-2  b)  or  MDAY-D2  (H-2 d)  cells  (Fig.  4 
A).  In  contrast,  mAbs  20-8-4S,  B22.249.R1,  and  30-5-7S 
that  recognize  the  a~  or  %  domains  of K s,  D 1',  or  L d  H 
chains,  respectively,  and  anti-8  antiserum  that  binds  to  the 
cytoplasmic tail of K a, were all capable of recovering TAP- 
class  I  complexes.  This  suggests  either  that  the  28-14-8S 
epitope is rendered inaccessible by TAP binding or that the 
binding  of this  mAb  disrupts  TAP-class  I  complexes.  The 
latter possibility was excluded because the amount of TAP- 
class  I  complexes  was  not  reduced  in  radiolabeled  cell ly- 
sates  after two rounds  of preclearance  with mAb  28-14-8S 
(data not shown). 
The  second line  of evidence comes from  analyses  of D a 
point  mutants  that  were  originally  generated  to  map  the 
CD8  binding  site  on  class  I  molecules.  It  has  been  shown 
that  H-2D d molecules  possessing  Glu  to  Lys  mutations  at 
residues  222  and  223  lose  the  ability  to  bind  to  CD8  and 
consequently  fail  to  stimulate  CD8-dependent  CTL;  the 
same  mutation  at  residue  232  is without  effect (26).  hater- 
estingly,  when  wild-type  D d and  mutants  E222K,  E223K, 
and  E232K  were immunoprecipitated  from cell lysates and 
the  immunoprecipitates  blotted  with  anti-TAP  antiserum, 
the E222K  mutant  was the only molecule that  failed to as- 
sociate with TAP (Fig. 4  B). This was not due to a defect in 
assembly with  ]32m  since  [~2nl  coimmunoprecipitated  with 
all  of the  D d H  chains  studied  (Fig.  4  C).  Taken  together, 
these  data  suggest  that  at  least  one  site  of interaction  with 
TAP  resides  in  the  membrane-proximal  region  of the  H 
chain ot  3 domain. 
TAP  and  Calnexin  Can  Associate  with  the  Same  Class  I 
Heterodimer.  We  previously demonstrated  that in addition 
to  associating  with  TAP,  mouse  H  chain-~zm  hetero- 
dimers  bind  to  the  molecular  chaperone,  calnexin  (12). 
tates were analyzed by SDS-PAGE after deglycosylation  with  endo  H. 
(Tbp) H chain region of gel; (middle) [32  m region of  gel; (bottom) a fourfold 
longer exposure of the first two lanes in the middle panel. 
342  Interactions between Class I Molecules, TAP, and Calnexin Thus, it was of interest to determine if class I heterodimers 
interact with TAP and calnexin separately or if the associa- 
tion  can  occur  through  a  ternary  complex  consisting of 
class I heterodimer, TAP1,2 heterodimer, and calnexin. 
As shown in Fig. 5 A, lane 2, when a radiolabeled lysate 
of EL4 cells was treated with the homobifunctional cross- 
linking agent DSP and then subjected to immunoprecipita- 
tion with a mixture of [32m-dependent anti-K  b and anti-D  b 
mAbs, cross-linked species corresponding to H  chain-[32m 
heterodimers  (,'-,60  kD)  and calnexin-H chain complexes 
(~160 kD) were detected. These species were absent from 
a control sample in which DSP was omitted (lane I). When 
anti-TAP2 antiserum was used for immunoprecipitation  of 
the DSP-treated lysate (lane 4),  it coprecipitated class  I  H 
chains as  expected  but  also  species  that  comigrated with 
cross-linked  H  chain-[32m  heterodimers  and  calnexin-H 
chain complexes (compare lane 2 with 4).  To confirm that 
a  calnexin-H chain cross-linked complex was  indeed re- 
covered in the  TAP immunoprecipitate, samples identical 
to those in lane 4 were solubilized and subjected to a sec- 
ond  round  of immunoprecipitation with  either  anti-K  b, 
anti-D  b,  or  anti-calnexin Abs  (lanes  5-7).  The  anti-class I 
Abs  recognized  uncross-linked H  chains,  low  levels  of a 
Db-~2  m  cross-linked complex (~60 kiD), several species of 
~100-kD, and an ",q60-kD species. The ~100-kD species 
have not been identified but the ~160-kD species was also 
recognized  by  the  anti-calnexin Ab  (lane  7),  confirming 
that it represented calnexin cross-linked to either K b or D b 
H  chains. The fact that anti-TAP antiserum was capable of 
recovering cross-linked H  chain-calnexin complexes dem- 
onstrates the existence of a ternary complex between TAP, 
class I heterodimers, and calnexin. 
We  next sought  to  quantitate the  proportion of TAP- 
associated class I heterodimers that are also bound to calnexin. 
EL4 cells were radiolabeled for  10 min with  [3SS]Met and 
then chased for 10 nfin to generate maximal levels of TAP- 
class  I  complexes,  As  shown in Fig.  5  B,  the  pulse-chase 
regimen was  effective  in producing predominantly [~2m- 
associated K b and D b molecules (lane 1) with relatively low 
levels  of free  H  chains  (lane  2).  Coimmunoprecipitation 
and immunodepletion techniques were then used to assess 
the amounts of H  chain-132m heterodimers that were asso- 
ciated  with  TAP,  with  calnexin, or  with  both  TAP  and 
calnexin. Anti-TAP2 antiserum was  used  to  coimmuno- 
precipitate  complexes  of  TAP  and  class  I  heterodimers 
(lane 3).  Densitometric analysis revealed that ~40% of K b 
heterodimers and ~60%  of D b heterodimers were  associ- 
ated with TAP (compare lane 1 with 3). Attempts to isolate 
complexes of calnexin and class  I  heterodimers by coim- 
munoprecipitation  with  anti-calnexin  antiserum  were 
complicated by the  presence of many other proteins that 
bound to this chaperone (lane 9). To circumvent this prob- 
lem,  the  amounts  of calnexin-class I  heterodimer  com- 
plexes  were  estimated by  clearing cell lysates  three  times 
with  either  preimmune  serum  or  anti-calnexin Ab  and 
then comparing the levels of K b and D b heterodimers that 
could be  recovered  in a  subsequent immunoprecipitation 
with [32m-dependent mAbs. As shown in lanes  11 and  12, 
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Figure 5.  Detection  of a complex between TAP, class I heterodimers 
and calnexin. (A) EL4 cells radiolabeled for 15 rain with [-~sS]Met were 
lysed in digitonin lysis buffer (pH 8) in the absence or presence of DSP. 
Cell lysates were subjected  to immunoprecipitation  either with a mixture 
of mAb Y3 and B22.249.R1 (K6/D  b) or with TAP2 antiserum. Where 
indicated, anti-TAP immunoprecipitates  were dissociated in SDS and then 
subjected to a second round of immunoprecipitation  with either anti-8 
antiserum (Kb), mAb 28-14-8s (Db), or  anti-calnexin antiserum (cnx). 
Samples were analyzed  by non-reducing SDS-PAGE (10% gel). The mo- 
bilities of cross-linked H chain-IB2m  (H.C.-~2m)  and H chain-calnexin 
(H. C.-cnx) complexes are indicated. The asterisk denotes an unidentified 
protein that appears irreproducibly  in some immunoprecipitates.  (B) EL4 
cells were radiolabeled  for 10 rain with [3sS]Met and then chased for 10 
min. Cells were lysed and equal aliquots of lysate were subjected to im- 
munoprecipitation  with either a mixture of nLAbs Y3 and B22-249.R1 
(to  recover IB2m-associated K  b and Db;  H.C./~2m),  anti-denatured H 
chain antiserum (to recover free H chains;free H.C.), anti-TAP2 antise- 
rum (TAP), or anti-calnexin  antiserum (cnx). To measure the amount of 
TAP-class I-calnexin ternary complexes, equal aliquots of lysate were 
subjected to three rounds of preclearance with either preimmune serum 
(P.L; lanes 4 and 7) or anti-calnexin  antiserum (lanes 5 and 8) before re- 
cover'/ of TAP-class I complexes with anti-TAP2 antiserum. To assess 
the level of calnexin-class I heterodimer complexes, two additional ali- 
quots of lysate were subjected to three rounds of clearance with either 
preimmune serum or anti-calnexin antiserum before recovery of class I 
heterodimers with a mixture of mAbs Y3 and B22-249.R1 (lanes 1t and 
I2). All immune complexes were digested with endo H before analysis  by 
SDS-PAGE under reducing conditions. 
the  recoveries  of both  K b and D 6 heterodimers  were  re- 
duced  after  preclearance  with  anti-calnexin antiserum  as 
compared to the recoveries after preclearance with preim- 
mune serum.  Densitometric analysis indicated that ,~45% 
ofK  b heterodimers and 85% ofD b heterodimers were asso- 
ciated with calnexin. These should be considered minimal 
estimates given the likelihood that some complex dissocia- 
tion occurred during the repeated clearances. A  similar  preclearance  approach  was used  to  determine 
the  amounts of class  I heterodimers  that were present  in a 
complex with  both  TAP  and  calnexin.  Duplicate  samples 
of lysate were  subjected to three  rounds  of clearance with 
either anti-calnexin Ab to remove all calnexin-associated pro- 
teins or with preimmune serum. TAP-associated H  chain- 
~2m  heterodimers  remaining  after  the  preclearances  were 
then compared after their recovery with anti-TAP2 antise- 
rum. As shown in lanes 4 and 5, preclearance with anti-cal- 
nexin Ab resulted in a reduction in the recovery of TAP- 
class  I  complexes.  This  confirms  that  class  I  heterodimers 
associate simultaneously with TAP and calnexin.  Densito- 
metric  analysis  revealed  that  in  two  separate  experiments, 
61-71%  of  TAP-associated  Kb-132  m  heterodimers  were 
cleared with the anti-calnexin  Ab and thus were bound to 
calnexin.  Likewise,  63-81%  of TAP-associated  Db-132  m 
heterodimers  were  present  as ternary  complexes with  cal- 
nexin. Again, these should be considered minimal estimates 
since  some  dissociation  of complexes  may have  occurred. 
Indeed,  a  reduction  in  TAP-class  I  complexes  was  ob- 
served when the levels of TAP-associated class  I molecules 
were  compared  after  direct  TAP  immunoprecipitation 
(lane 3)  or after three rounds of clearance with preimmune 
serum  (lane  4).  The  extent  of complex dissociation varied 
between  experiments.  For example,  when the  experiment 
was repeated  using LLnL to limit peptide  supply,  virtually 
no  losses  of TAP-class  I  complexes  were  observed  when 
levels  were  compared after  direct  TAP  immunoprecipita- 
tion  (lane  6)  or after three  clearances with preimmune  se- 
rum (lane  7). Furthermore,  preclearance with anti-calnexin 
antiserum  resulted  in a dramatic  reduction in the recovery 
of both TAP-K  b and TAP-D  u complexes  (compare lane  7 
with  8);  82% of TAP-associated KU-132  m  heterodimers  and 
83% of TAP-associated Db-~32  m  heterodimers were present 
as ternary complexes with calnexin. 
Differential Effects of Peptide Binding  to Class I Molecules on 
the Dissociation of TAP and Calnexin.  Although  the  bind- 
ing of peptide  ligands  to  class  I  heterodimers  is  associated 
with release of the TAP transporter, it is not clear ifpeptide 
binding is sufficient to induce calnexin dissociation. 
To assess the  effects of peptide  binding to  class  I  mole- 
cules  on  the  dissociation  of TAP  and  calnexin,  EL4  ceils 
were again radiolabeled for 10 rain with  [3SS]Met  and then 
chased for 10 min  to  generate  predominantly  ~32m-associ- 
ated  K u and  D b molecules  (Fig.  5  B,  lanes  1 and  2).  The 
ceils  were  permeabilized  with  digitonin  and  incubated  in 
the  absence  or  presence  of  K  b-  or  Db-specific  peptide 
ligands. After cell lysis,  TAP-class I complexes were recov- 
ered  by  coimmunoprecipitation  with  anti-TAP2  antise- 
rum.  Consistent with previous results  (reference 9 and Fig. 
3 A), incubation of permeabilized cells with either the K b- 
restricted  VSV  G  52-59  peptide  or  the  Db-restricted  Flu 
NP  Y367-374  peptide  led  to  the  selective  dissociation  of 
80%  of TAP-K  b and  70%  of TAP-D  b complexes,  respec- 
tively (Fig. 6, lanes  1-3;  quantitation  by densitometry).  K b 
and D b molecules bound to calnexin (consisting almost ex- 
clusively of H  chain-132m  heterodimers;  see  previous  sec- 
tion)  were  isolated  by  sequential  immunoprecipitation. 
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Figure 6.  Effects  ofpeptide binding to class I on dissociation from TAP 
and calnexin. EL4 cells were radiolabeled for 10 min with [3sS]Met and 
chased for 10 rain. Cells were permeabilized with 0.003% digitonin and 
then incubated in the absence or presence of 10 p,M Db-binding  peptide, 
Flu NP u  (/Tu), or 10 p~M Kb-binding peptide, VSV G 52-59 
(vsv), as indicated. After  lysis in digitonin lysis buffer, TAP-associated  class 1 
molecules were recovered with anti-TAP2 antiserum (lanes 1-3). Class 1 
molecules bound to calnexin were isolated by initial precipitation with 
anti-calnexin antiserum, followed by solubilization of the immunoprecip- 
itate in SDS and subsequent inununoprecipitation of K  b and D  b with a 
mixture of anti-8 antiserum, mAb 28-14-8s, and anti-denatured H chain 
antiserum (lanes 4,  5,  7-9). P.I. denotes pre-immune serum. Imnmne 
complexes were digested with endo H before analysis by reducing SDS- 
PAGE. 
This involved an initial precipitation with anti-calnexin an- 
tiserum to recover all calnexin-associated proteins and, after 
dissociation  of  complexes  in  SDS,  immunoprecipitation 
with a mixture ofanti-K  b and anti-D  b antibodies. As shown 
in  Fig.  6,  lanes  4  and  5,  incubation  of the  permeabilized 
cells  simultaneously with  the  K b- and Db-specific peptides 
resulted in little,  if any, loss of calnexin-associated D b mol- 
ecules but a significant reduction in calnexin-associated K b 
molecules.  The  experiment  was repeated  using permeabi- 
lized cells  incubated with each peptide separately with sim- 
ilar  results  (Fig.  6,  lanes  6-9).  Densitometric  analysis  re- 
vealed  that,  for the  two  experiments,  peptide  binding  to 
class I led to a 15-30% reduction in calnexin-K  b complexes 
and  a  3-9%  reduction  in  calnexin-D  b complexes.  There- 
fore,  peptide  binding to  calnexin-associated  H  chain432m 
heterodimers  can induce some dissociation from the chap- 
erone,  but  clearly not to the  extent  observed for peptide- 
induced dissociation of TAP-class I complexes. 
Discussion 
In this report,  we demonstrate that class  I molecules ex- 
hibit prolonged association with TAP under peptide limit- 
ing  conditions  imposed  by  inhibiting  proteolytic  activity 
with the peptide aldehyde, LLnL. This finding supports the 
notion that class I molecules associate with TAP in order to 
facilitate  acquisition  of  appropriate  peptide  ligands.  Al- 
though  both  K b  and  D b  remained  bound  with  TAP  for 
prolonged periods in the presence of LLnL, they differed in 
the extent to which LLnL treatment enhanced their associ- 
ation with TAP and in the kinetics of their dissociation.  In 
the case of K b, LLnL treatment resulted  in a roughly four- 
fold increase  in  the  level  of heterodimers  bound  to  TAP 
whereas little  change was observed in the level of TAP-D  b 
complexes.  This  observation  suggests  that  under  normal 
conditions, peptides capable of binding to K b may be more 
abundant than Db-specific peptides, and hence TAP-bound 
I Molecules, TAP, and Calnexin K b molecules  may acquire  peptide  and  dissociate  rapidly 
from  TAP  with  little  opportunity  to  accumulate.  Even 
when  peptide  supply was  inhibited  with  LLnL,  TAP-K  b 
complexes  dissociated  more  rapidly  than  TAP-D  b  com- 
plexes. This may reflect an inherent lower affinity of TAP 
for K b or, alternatively, that K b can acquire peptides more 
readily than D b from sources not inhibited by LLnL. The 
prolonged association ofK  b and D b molecules with TAP in 
LLnL-treated  cells  was  accompanied  by  a  concomitant 
slowing of EIL to Golgi transport. Although this is sugges- 
tive of a role for TAP in retaining peptide-deficient class I 
molecules in the El<, such a conclusion is complicated by 
the observation that the TAP-class I complexes also inter- 
act with the resident El< chaperone, calnexin (see below). 
The finding that class I molecules associate with TAP only 
after H  chain-[32m assembly (9,  10) and that the interaction 
is affected either by peptide depletion or by peptide binding 
to class I  (9,  10 and Fig.  1), suggests that regulation of the 
TAP-dass I interaction is achieved by conformational changes 
associated with  [32m and peptide binding to  the  H  chain. 
Although there is some evidence that the H  chain cytoplas- 
mic tail exhibits structural differences between [32m-bound 
and unbound states (36,  37),  it is the extracellular domains 
of the  H  chain  that  most  clearly  reflect  conformational 
changes induced by 132m and peptide binding (29,  32,  38- 
42). Thus, it is perhaps not surprising that we found the ex- 
tracellular (ElL luminal)  portion of class I molecules to be 
sufficient for peptide-regulated interaction with TAP. 
It  is  noteworthy  that  the  non-classical,  GPI-anchored 
class  I  molecule,  Q7  b,  associated  efficiently  with  TAP. 
Since recent work using a mutant human ceil line has sug- 
gested that class I association with TAP is necessary for nor- 
mal acquisition  of peptide ligands  (43),  the  existence of a 
TAP-Q7  b complex is consistent with the finding that Q7  b 
molecules  are  occupied  by  peptides  (44).  In  contrast  to 
Q7 b, little of the soluble class I molecule, Da/Q10, was re- 
covered in association with TAP.  This may suggest that a 
membrane-anchor is required for stable TAP association in 
vivo  or,  alternatively,  that  TAP  complexes  with  soluble 
class I molecules are more labile during immunoisolation. 
We favor the latter hypothesis because ~'-'85-95% of these 
soluble molecules have been shown to be peptide filled (D. 
Margulies, personal communication) and a soluble form of 
the Q7 b molecule has also been shown to contain a diverse 
array of peptides (45).  Very recently, a soluble form of the 
L  d molecule,  Ld/Q10  was  demonstrated  to  interact  with 
TAP but no indication of the efficiency of the interaction 
was provided (20). 
TAP  associates  with  class  I  heterodimers  through  the 
TAP1 subunit (9, 46). To localize where a TAP interaction 
site resides within the extracellular portion of class I mole- 
cules we probed different domains of class I molecules with 
a panel of antibodies and also tested H  chain point mutants 
for their  ability  to  associate  with  TAP.  Both  approaches 
suggest a TAP interaction site within the ot  3 domain. The 
antibody experiments revealed that reagents directed against 
ot  1,  or2, or  cytoplasmic  domains  recognized  TAP-class  I 
complexes but the ot  3 domain-specific mAb, 28-14-8S, did 
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not. It is noteworthy that another %  domain-specific mAb, 
34-2-12S,  was  capable  of recognizing  TAP-class  I  com- 
plexes. This difference is likely due to the distinct locations 
of their respective epitopes. The 28-14-8S epitope appears 
to be within  13 strand 6  of the o~  3 domain of D b or L  d in- 
volving residues 260-262  (47 and G. Waneck, unpublished 
data)  whereas  the  34-2-12s  epitope  involves  residue  227 
within the loop joining [3 strands 3 and 4 in the D d %  domain 
(26).  Of three D d point mutants tested, only a Glu -+ Lys 
mutation at position 222 failed to bind to TAP.  This resi- 
due  resides  in  a  conserved acidic  loop  (amino  acids  222- 
229)  in the membrane proximal portion of the %  domain 
that  constitutes  a  major interaction  site  for CD8  binding 
(26,  48).  Although  preliminary, this  observation raises  the 
interesting possibihty that to associate with a broad range of 
class I molecules, the TAP transporter uses a portion of the 
highly conserved CD8 binding site. A TAP-interaction site 
on the  membrane-proximal area  of the  %  domain  is also 
consistent with the predicted small loops of the transporter 
that penetrate the lumen of the El< (3, 4). 
It is  of interest  that  most  of the  anti-class  I  mAhs  we 
found to be capable of recognizing TAP-class I complexes 
were  directed  against folded  determinants  in  the  H  chain 
cq- and ~2-domains.  l<ecent work by Carreno  et al.  (20) 
concluded that only "open" forms of the H-2L  a molecule 
associate with TAP and that folded L a molecules detectable 
with  conformation-dependent  mAbs such  as B22.249.l<1 
and  30-5-7S  do  not  bind  to  TAP.  Our  findings  are  not 
consistent with this conclusion. Not only did mAb 30-5-7S 
recognize  folded  La-TAP  complexes,  but  the  conforma- 
tion-dependent mAbs B22.249.l<1  and 20-8-4S were effec- 
tive in recovering folded Db-TAP and Kb-TAP complexes, 
respectively (Fig.  4 A). The basis for this discrepancy is un- 
known but may reflect the different cell lines employed in 
the  two studies.  The same group also  examined a human 
cell line lacking classical class I H  chains and obtained evi- 
dence suggesting that TAP may associate directly with 132m 
(20).  This raises  the  possibility that  TAP interaction with 
class I heterodimers could be mediated through [32 m.  Such 
a  possibility is  not  supported by our  data.  First,  we  have 
consistently been unable to observe any newly synthesized 
free  132  m  associating with  TAP  at  early  chase  times  after 
pulse radiolabeling (e.g., Fig.  1 A). Second, the Gtu --+ Lys 
mutant at position 222 of the D a H  chain retains association 
with ~2 m  but does not bind to TAP. Perhaps a low affinity 
TAP-132m interaction  can be detected  only under  condi- 
tions  of H  chain deficiency or,  alternatively, the presence 
of non-classical  H  chain-J32m  heterodimers  could  be  re- 
sponsible for the observed association. 
Since class I heterodimers interact with calnexin as well 
as with TAP it is important to determine if these complexes 
occur separately or if TAP,  class I  heterodimers,  and cal- 
nexin associate in a large, muti-component complex. This 
issue  is particularly relevant from the standpoint  of quality 
control in the biogenesis of class I molecules. Peptide-defi- 
cient heterodimers are largely retained within the ElL (49) 
and there is some controversy concerning the relative roles 
of calnexin and TAP as effectors of this retention (10,  20). We confirmed our previous observations that a substantial 
portion  (40-60%  or  more)  of K b  and  D b  heterodimers 
could  be  detected  in  complexes  with  TAP  (9).  Further- 
more,  most heterodimers could be  detected in  association 
with calnexin (45% for K b and 85% for D b) consistent with 
our  earlier findings  (12).  Note  that  the  relatively low  re- 
covery of calnexin-K  b heterodimer complexes seems to be 
a  consequence  of a particularly labile interaction since an- 
other K  locus product, K d, exhibits near quantitative bind- 
ing of H  chain-~2m  heterodimers  to  calnexin  (12).  Most 
importantly, we observed that as much as 70-80% of those 
heterodimers that associated with TAP were also associated 
with  calnexin.  Thus,  it  appears  that  heterodimers  exist 
mainly as binary complexes with calnexin or as ternary com- 
plexes with  TAP  and  calnexin;  the  pool  of heterodimers 
that bind only to TAP is quite small. 
Our findings suggest a  model for the major pathway in 
the  biogenesis of mouse  class  I  molecules.  In  this  model, 
newly synthesized H  chains bind quantitatively to calnexin 
(12,  13)  and the interaction is maintained during H  chain 
assembly with ~2m.  Most of the calnexin-bound H  chain- 
[32  m  heterodimers then associate with TAP to form a large, 
ternary complex. After their acquisition of peptide ligand, 
class  I  molecules dissociate from  TAP  but  remain  largely 
bound to calnexin. This latter point is based on our obser- 
vation that  the introduction of peptide into permeabilized 
cells results in almost complete dissociation of K 6- and D 6- 
]~2  m  heterodimers from TAP whereas only 15-30%  of K 6 
and  <10%  of D b heterodimers are released from calnexin. 
The  inability of peptide  ligand  to  dissociate  calnexin-L  d 
complexes  in  detergent  lysates has  also been  reported  re- 
cently, although it was not clear if the complexes contained 
predominantly  flee  L d  H  chains  or  Ld-]32  m  heterodimers 
(20).  In the last stage of the model,  dissociation from cal- 
nexin occurs and the fully assembled class I molecule is ex- 
ported from  the ElL for transport to  the cell surface.  The 
nature of the event that permits class I release from calnexin 
remains unknown,  but it appears to occur shortly after dis- 
sociation from TAP since the kinetics of dissociation from 
TAP, release from calnexin, and transport to the Golgi are 
essentially identical within  the  resolution of our  assays (9, 
12). In this model, both TAP and calnexin may participate 
in the EI~ retention of peptide-deficient heterodimers, but 
calnexin  is  the  nmlecule  that  ultimately  detemfines  if a 
mouse  class I molecule is exported to the Golgi apparatus. 
It  is  important  to  consider  the  possibility that  additional 
components  may participate  in  the  formation  or  mainte- 
nance of the TAP-class I-calnexin complex. The discovery 
of a  gene linked to the human  MHC  that seems to be re- 
quired  for  TAP-class  I  association is  consistent  with  an- 
other component playing a  role either in delivering class I 
molecules to TAP or in mediating their interaction (43). 
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